Navigation Links
InVitria Expands Sales Team
Date:8/26/2008

Global Supplier of Animal Free Products for Biopharmaceutical, Cell Culture, Life Science Research and Diagnostics Industry Adds Seasoned Sales Professional to Help Rapidly Expanding Customer Base Improve Productivity,

Safety and Time to Market

FORT COLLINS, Colo., Aug. 26 /PRNewswire/ -- InVitria (http://www.invitria.com), a leading global supplier of animal free products that enhance productivity, safety and time to market for companies in the biopharmaceutical, cell culture, life science research and diagnostics industry, today announced the addition of seasoned professional Ray Tritch to its expanding Sales Team. Mr. Tritch will work with customers throughout the Eastern United States.

"We are very excited to welcome Ray to our sales team," said InVitria President, Scott Deeter. "As our customer base expands, Ray will be vital in ensuring InVitria's core values of customer service, partnership and innovation remain at the forefront of everything we do."

Mr. Tritch will leverage his significant history of success with companies including Jackson Laboratories, Invitrogen (formerly Life Technologies) and Serologicals as he works with customers to help them achieve advantages in their operations, including mammalian cell culture, bacterial fermentation and biopharmaceutical formulation, as well as other applications.

"I couldn't be happier about this newest stage in my professional journey," said Mr. Tritch. "The array of animal free products I will have in my toolkit will enable me to provide innovative, cost efficient, time saving and safe solutions to both existing and future InVitria customers.

"For example, Cellastim, an albumin used to replace bovine albumin and human albumin as a cell culture ingredient and biopharmaceutical formulation excipient, has been shown to improve mammalian cell culture productivity by up to 50% when compared with other forms of albumin. Lacromin, a lacto transferrin, can be used as a cell culture ingredient to improve productivity and safety versus bovine and human transferrin. And Lysobac is a bacterial cell lysis agent that is more efficient and consistent compared to chicken lysozyme.

"These animal free products represent the future in this industry -- the 'holy grail' of ingredients for the cell culture market -- and I am extremely proud to represent them as a part of the InVitria team."

To learn more about InVitria's animal free products, please email info@invitria.com or call 1-800-916-8311. Ray Tritch can be contacted directly at RTritch@InVitria.com.

About InVitria (http://www.invitria.com)

InVitria has developed animal free products that enhance productivity, safety and time to market for companies in the biopharmaceutical, cell culture, life science research and diagnostics industry. InVitria's animal free product line includes:

-- Cellastim -- An albumin used to replace bovine albumin and human albumin as a cell culture ingredient and biopharmaceutical formulation excipient. Cellastim has been shown to improve mammalian cell culture productivity by up to 50% when compared with other forms of albumin. Cellastim also has been an effective component in stem cell media.

-- Lacromin -- Lacromin has been shown to replace bovine transferrin and human transferrin in cell culture media. In addition, at higher inclusion levels, Lacromin is a strong growth promotant as a supplement for mammalian cell culture media.

-- Lysobac -- A bacterial cell lysis agent that is more efficient and more consistent compared to chicken lysozyme. Lysobac is used in bacterial fermentation to improve recombinant protein yields.

To learn more about InVitria, please e-mail info@invitria.com or call 1-800-916-8311.


'/>"/>
SOURCE InVitria
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. InVitrias Animal Free Lacromin(TM) Provides a Cost-Effective Improvement Over Transferrin
2. Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare
3. Hoya Vision Care Expands in Czech Republic
4. MicuRx Pharmaceuticals Selects Next-Generation Antibiotic Candidate Targeting MRSA and Expands Operation in China
5. GenVault Expands Scientific Advisory Board
6. NeoStem Expands Adult Stem Cell Collection Network, Gains Footprint in Key Los Angeles Market and Initiates Waitlist
7. Raptor Pharmaceuticals Expands Board of Directors and Scientific Advisory Board
8. Brinks Hofer Gilson & Lione Expands to High-Tech Raleigh/Durham Area; Adds Accomplished Patent Attorneys to Its New Office
9. SAFC Supply Solutions Expands Halal Offer in Flavors & Fragrances Product Line
10. PAREXEL Expands Global Clinical Logistics Capabilities
11. BioXcel Expands Its Capability in Business Analytics Support Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... and CEO, Jim Joyce . In ... Saturday, Bill Gates warned world leaders that ... nuclear weapons. Mr. Gates expressed his concern, which is ... scientific terrorists have access to the necessary tools to ...
(Date:2/24/2017)... Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), ... announced its financial results for the fourth quarter and fiscal ... Highlights Total sales in the fourth ... increased by 13.6% in USD terms to $77.6 million from ... Gross profit increased by 13.3% to $46.8 million from ...
(Date:2/23/2017)... ... February 23, 2017 , ... BellBrook Labs ... to include an array of biochemical analyses critical for Lead Discovery. The ... hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism of action, and ...
(Date:2/23/2017)... 2017  Imanis Life Sciences announced today the ... vaccinia viruses for virotherapy research. These viruses are ... proprietary, vaccinia virus-based technology platform for research use. ... a partnership with Genelux to offer researchers, for ... use in research," said Dr. Kah Whye ...
Breaking Biology Technology:
(Date:2/22/2017)... -- With the biometrics market to exceed $10 ... that innovative and agile startups must incorporate into ... changing competitive landscape: multifactor authentication (MFA), point-of-sale (PoS), ... "Companies can no longer afford to cut corners ... Pavlakis , Industry Analyst at ABI Research. "Pairing ...
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist Medical ... its new chief executive officer (CEO). Freischlag joins the ... John D. McConnell , M.D., who last year announced ... the Medical Center, after leading it since 2008.   ... scope of Wake Forest Baptist,s academic health system, which ...
Breaking Biology News(10 mins):